Treatment stores

Gastrointestinal Bleeding Treatment Market – 42% of Growth Comes from North America | Driven by favorable initiatives and a growing prevalence of gastrointestinal diseases

NEW YORK, May 10, 2022 /PRNewswire/ — Gastrointestinal Bleeding Treatment Market Size Expected to Increase by $188.19 million from 2021 to 2026 to a CAGR of 4.63% according to Technavio’s latest market report. 42% of market growth will come from North America during the forecast period. The United States is the key market for the treatment of gastrointestinal bleeding in North America. The growth of the market in this region will be faster than the growth of the market in Europe and LINE. High adoption of technology, rising prevalence and incidence of gastrointestinal diseases, growing geriatric population, and growing presence of prominent vendors developing endoscopic devices will facilitate the growth of the market for treatment of gastrointestinal bleeding North America over the forecast period.

Technavio has announced its latest market research report titled Gastrointestinal Bleeding Treatment Market by Product and Geography – Forecast and Analysis 2022-2026

For more insights on the market share of different regions – Download a sample report in MINUTES

Read the 120-page report with TOC on “Gastrointestinal Bleeding Treatment Market Analysis Report by Product (Endoscopic Mechanical Devices, Thermal Endoscopic Devices, and Others) and Geography (North America, Europe, Asiaand Rest of the World (ROW)), and Segment Forecast, 2022-2026″. Gain competitive insights on market leaders. Track key industry opportunities, trends, and threats. Marketing insights, brand, strategy and market development, sales, and supply functions. https://www.technavio.com/report/report/gastrointestinal-bleeding-treatment-market-industry-analysis

Gastrointestinal Bleeding Treatment Market: Drivers and Challenges

The key factors driving the growth of the global gastrointestinal bleeding treatment market are the favorable initiatives and the growing prevalence of gastrointestinal diseases. The increasing prevalence of esophageal, colorectal, gastric cancers and colon polyps will further augment the market growth. For example, according to the CDC, approximately 3.5 million adults were screened for colorectal cancer in 2018. Likewise, awareness of gastrointestinal bleeding has increased among physicians and patients in recent years. In addition, various countries such as the United States, Germany, and the UK have screening initiatives in place. In addition, governments, private institutions and major suppliers have intensified their awareness campaigns on gastrointestinal diseases. For example, Olympus, a key vendor in the market, has designated March every year as Colon Cancer Awareness Month and conducts various awareness programs. These factors will drive the growth of the market over the forecast period.

However, the main challenge for the growth of the global gastrointestinal bleeding treatment market is high treatment costs. This makes market penetration difficult, especially in price-sensitive markets such as developing and emerging economies. Even in developed countries, small hospitals and private clinics may not opt ​​for endoscopic kits due to budget constraints. Equipment maintenance is another factor that adds to the financial burden on end users. Surgeons in developing and emerging countries are still reluctant to choose endoscopic surgeries due to their high price. Advances in endoscopic procedures have increased the prices of endoscopic systems, making treatments unaffordable for most patients in developing economies. The high cost of the procedure and the lack of reimbursement in developing economies will hamper the market growth over the forecast period.

To know the other pilots & challenges – Download a sample now!

Some of the major players in the treatment of gastrointestinal bleeding:

The gastrointestinal bleeding treatment market is fragmented and vendors are deploying growth strategies such as investing in research and development (R&D) to compete in the market.

Gastrointestinal Bleeding Treatment Market: Segmentation Analysis

Product Outlook (Revenue, USD Million, 2021-2026)

  • Endoscopic mechanical devices – size and forecast 2021-2026

  • Endoscopic thermal devices – size and forecast 2021-2026

  • Others – size and forecast 2021-2026

Geographic Outlook (Revenue, USD Million, 2021-2026)

  • North America – size and forecast 2021-2026

  • Europe – size and forecast 2021-2026

  • Asia – size and forecast 2021-2026

  • Rest of the world (ROW) – size and forecast 2021-2026

Know the market contribution of each segment – Get an exclusive sample report

Don’t wait, take a strategic approach and boost your business goals with our Gastrointestinal Bleeding Treatment Market Forecast Report – Buy now!

Related reports:

  • the orthopedic implants market share from 2021 to 2026 is USD 15.45 billion at a progressive CAGR of 7.73%. Download a sample now!

  • the vascular graft market share is expected to increase by $1.55 billion by 2026, and the growth momentum of the market will progress at a CAGR of 7.22%. Download a sample now!

Scope of Gastrointestinal Bleeding Treatment Market

Report cover

Details

Page number

120

Year of reference

2021

Forecast period

2022-2026

Growth momentum and CAGR

Accelerate at a CAGR of 4.63%

Market Growth 2022-2026

$188.19 million

Market structure

Fragmented

Annual growth (%)

3.73

Successful market contribution

North America at 42%

Competitive landscape

Leading companies, competitive strategies, scope of consumer engagement

Profiled companies

Boston Scientific Corp., Conmed Corp., Cook Group Inc., EndoClot Plus Inc., Erbe Elektromedizin GmbH, Mayo Foundation for Medical Education and Research, Medtronic Plc, Olympus Corp., OVESCO ENDOSCOPY AG, STERIS Plc and University Hospitals

Market dynamics

Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, COVID 19 Impact and Future Consumer Dynamics, Market Condition Analysis for the Forecast Period,

Personalization area

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Contents

1. Summary

2 Market landscape

3 Market sizing

4 Five forces analysis

5 Market Segmentation by Product

6 Customer Landscape

7 Geographic landscape

8 drivers, challenges and trends

9 Supplier Landscape

10 Vendor Analysis

11 Appendix

About Technavio

Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
E-mail: [email protected]
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)

Quote

Quote

Show original content to download multimedia:https://www.prnewswire.com/news-releases/gastrointestinal-bleeding-treatment-market—42-of-growth-to-originate-from-north-america-driven-by-favorable-initiatives–increasing -prevalence-of-gastrointestinal-diseases-technavio-301542566.html

SOURCETechnavio